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Abstract 
 
Natural peptides with antimicrobial properties are deeply investigated as tools to fight bacteria 
resistant to common antibiotics. Small peptides, as those belonging to the temporin family, are very 
attractive since their activity can easily be tuned after small modification to their primary sequence. 
Structure-activity studies previously reported by us allowed the identification of one peptide, 
analogue of temporin B, TB_KKG6A, showing, unlike temporin B, antimicrobial activity against 
both Gram positive and Gram negative bacteria. In this paper we investigated the antimicrobial and 
anti-inflammatory activity of the peptide TB_KKG6A against Pseudomonas aeruginosa. 
Interestingly we found that the peptide exhibits antimicrobial activity at low concentrations, being 
able to down-regulate the pro-inflammatory chemokines and cytokines IL-8, IL-1β, IL-6 and TNF-
α  produced downstream in infected human bronchial epithelial cells. Experiments were carried out 
also with Temporin B, which was found to show pro-inflammatory activity. Details on the 
interaction between TB_KKG6A and the P. aeruginosa LPS were obtained by CD and fluorescence 
studies.  
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 1. Introduction 
Cystic fibrosis (CF) is a severe and diffuse recessive genetic disease due to defects of the CF 
Transmembrane conductance Regulator (CFTR) gene.
1
 CF affects several organs, with the chronic 
pulmonary disease being the major cause of reduction of the quality and expectancy of life. The 
hallmark of CF lung disease is chronic infection generally sustained by the Gram-negative 
bacterium Pseudomonas aeruginosa (P.aeruginosa) and excessive lung inflammation with a huge 
infiltrate of neutrophils in the bronchial lumen, mainly due to the release of the chemokine 
interleukin IL-8.
2-5
 The identification of innovative drugs, exhibiting strong antibacterial activity 
and thereby able to reduce the excessive lung inflammation in CF patients, is considered a 
promising therapeutic strategy to prevent the progressive lung tissue deterioration. Unfortunately, 
many of the known antibacterial molecules targeting P. aeruginosa have important undesired side 
effects. The ability of bacteria as P. aeruginosa to adapt themselves to the CF pulmonary 
environment and to form biofilms resistant to commonly used antibiotics renders the research of 
new molecules against such bacteria compelling.
6
  
To this aim, antimicrobial peptides have been proposed as a tool to overcome bacterial 
insusceptibility.  The search of drugs able to kill strains resistant to common antibiotics led to the 
discovery and design of several peptides, derived from natural fonts, with improved antibacterial 
and anti-inflammatory activities. Peptides derived from thrombin were found able to inhibit the 
inflammatory response and reduce mortality in a mouse model of P. aeruginosa induced sepsis
7
; the 
peptide Api88 derived from aepidaecin shows strong antibacterial activity against Gram negative 
bacteria including several isolates of P. aeruginosa, without evidences of immunomodulatory 
activity.
8
 Several peptides between those isolated from frog skin have been tested and found active 
against P. aeruginosa strains
9-12
: the esculentin derivative Esc(1-21) was reported to be highly 
active against P. aeruginosa isolated from CF patients, having the ability to prolong the survival of 
animals in models of P. aeruginosa infections.
13
  
In order to identify novel molecules active against P. aeruginosa, we have focused our 
attention on antimicrobial peptides belonging to the temporin family. Temporins are short peptides 
secreted by the granular glands of the European frog Rana Temporaria, mainly active against Gram 
positive bacteria
14, 15
. The only member of the temporin family showing activity also against Gram 
negative bacteria is temporin L, whose activity and structure in membrane like environment has 
been deeply investigated
16, 17
. The antimicrobial activity of the peptide Temporin-1Tb (TB) has 
been investigated on multidrug resistant clinical isolates of P. aeruginosa and on a C. elegans 
model
9
: it has been found that although TB promotes the survival of infected nematodes, it does not 
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display antimicrobial activity in vitro. Studies focused on Temporin B analogues demonstrated that 
subtle changes of the peptide primary structure result in new and interesting biological properties: 
addition of a tripeptide KKY at the N-terminus of temporin B produces the peptide TB-KK which 
acts in synergy with temporin A against Gram positive and Gram negative bacteria also in vivo
18
. 
TB-KK in combination with an analog of royal jellein I (RJI-C), an antimicrobial peptide isolated 
from the bee jelly, is strongly active against S. epidermidis; the combination of TB-KK and RJI-C 
does not kill probiotic bacteria and in vivo, in cells stimulated with LPS, down regulates the level of 
the pro-inflammatory cytokines TNF−α and IFN-γ while enhancing the expression of the anti-
inflammatory cytokine IL-10, to an extent comparable with gentamicin
19
.  
The recently developed TB analogue TB_KKG6A, unlike TB, shows activity against Gram 
positive and Gram negative bacteria at low concentrations
20
. Compared to TB, this peptide has 
glycine 6 replaced by alanine and two extra lysines at the N-terminus. Fluorescence, CD and NMR 
data demonstrated that this peptide strongly interacts with the E. coli LPS and folds into a helix 
upon binding. Unlike TB, TB_KKG6A does not aggregate on LPS, probably due to the high 
number of positive charges and interestingly does not show hemolytic activity. The features 
discovered for TB_KKG6A encouraged us to explore the antimicrobial activity of this peptide 
against microorganisms as P. aeruginosa. 
 
The aim of the present study was to determine the activity of TB_KKG6A on P. aeruginosa 
growth and downstream biological effects on the cystic fibrosis IB3-1 cell line (see Table 1 for 
peptide sequences). This cell line, after exposure to P. aeruginosa activates several pro-
inflammatory cytokines and chemokines, as published by some of us.
21, 22
 We investigated the 
antimicrobial activity of TB_KKG6A against P. aeruginosa strain PAO1 and the amount of IL-8, 
IL-1β, IL-6 and TNF-α produced in IB3-1 cells in different experimental conditions. Interactions of 
TB_KKG6A with bacterial LPS were investigated by Circular Dichroism with the aim to determine 
the secondary structure assumed by the peptide on bacterial cells and by fluorescence to gain 
information on the peptide-LPS binding.  
 
 
2. Material and Methods 
 
2.1 Peptide synthesis 
Peptides were synthesized on solid phase by Fmoc chemistry on the MBHA (0.54 mmol/g) 
resin by consecutive deprotection, coupling and capping cycles. 
19
 
20
 Deprotection: 30% piperidine 
Page 3 of 25
http://mc.manuscriptcentral.com/jpsc
Journal of Peptide Science
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
in DMF, 5 min (2×). Coupling: 2.5 equivalents of amino acid+2.49 equivalent of HOBT/ HBTU 
(0.45 M in DMF)+3.5 equivalents NMM, 40 min. Capping: acetic anhydride/DIPEA/DMF 15/15/70 
v/v/v, 5 min. Peptides were cleaved off the resin and deprotected by treatment of  the resin with a 
solution of TFA/TIS/H2O 95/2.5/2.5 v/v/v, 90 min. TFA was concentrated and peptides were 
precipitated in cold ethylic ether.  
Analysis of the crudes was performed by LC–MS using a gradient of acetonitrile (0.1% TFA) in 
water (0.1% TFA) from 30 to 70% in 30 min. Purifications were performed by semipreparative RP-
HPLC using a gradient of acetonitrile (0.1% TFA) in water (0.1% TFA) from 30 to 70% in 30 min.  
The conjugation of the peptide to NBD was carried out on solid phase, on the peptide derivatized 
with a 6 amino-hexanoic acid (Ahx) linker at the N-terminus. NBD-Cl was reacted with the free 
amino group of Ahx in the presence of NMM.
20
 . NBD-Cl (5 eq.) was dissolved in DMF, NMM (7 
eq) was added; the solution was reacted with the peptide 3 hours at r.t. and double couplings were 
performed. 
Peptides were cleaved off the resin and deprotected by treatment of the resin with a solution of 
TFA/TIS/H2O 95/2.5/2.5 v/v/v, 90 minutes. TFA was concentrated and the peptides were 
precipitated in cold ethylic ether. Analysis of the crudes was performed by LC-MS using a gradient 
of acetonitrile (0.1% TFA) in water (0.1% TFA) from 30 to 70% in 30 minutes. Purification was 
performed by semipreparative RP-HPLC using a gradient of acetonitrile (0.1% TFA) in water 
(0.1% TFA) from 30 to 70% in 30 minutes. Characterization of the peptides by LC-MS confirmed 
previously reported results 
20
.   Peptides sequences and names are reported in Table 1. 
 
2.2. Cell lines and bacteria   
IB3–1 cells, derived from a CF patient with a ∆F508/W1282X mutant genotype and immortalized 
with adeno12/SV40, were grown in LHC-8 supplemented with 5% FBS in the absence of 
gentamicin, at 37 °C/ 5% CO2.
23
 The effects of active principles were analyzed as elsewhere 
described.
24
 The nonmucoid laboratory strain of P. aeruginosa, PAO1, has been donated by A. 
Prince (Columbia University, New York, NY). Bacteria colonies from overnight cultures on 
trypticase soy agar (Difco, Detroit, MI) plates were grown with shaking in 20 ml trypticase soy 
broth (Difco) at 37°C until an OD (A660 nm wavelength), corresponding to 1.5 x 10
7
 CFU/ml, was 
reached. Bacteria were washed twice with PBS and diluted in each specific serum-free medium 
before infection and added to cells at the concentration indicated as CFUs per cell. 
 
2.3. Anti-microbial activity assay 
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The anti-microbial activity of peptides was determined following the procedure for the Minimum 
Inhibitory Concentration (MIC) of the National Committee for Clinical Laboratory Standards. In 
brief, P. aeruginosa was cultured on plates of Tryptic Soy Agar (TSA) overnight at 37 °C. The 
colonies were harvested, suspended in sterile saline, and adjusted to a concentration of a 0.5 
McFarland standard. The range of TB and derivatives concentrations tested (as indicated in the 
figure) was prepared in 15 ml tubes containing 5 ml of Tryptic Soy Broth (TSB) starting from a 
1000-fold concentrated of each compound stock solution. McFarland 0.5 standard of P. aeruginosa 
(20 µl) was added to each tube, and samples were incubated at 37 °C for 24 h. MIC is defined as the 
lowest concentration of compound at which there is no visible growth of the organism. In addition, 
the samples were read at 660 nm wavelength for quantitative analysis with a Beckman DU 640 
spectrophotometer. 
 
 
2.4. Quantification of mRNA content 
Total RNA was extracted using TRIzol Reagent (Sigma, St. Louis, MO) following the 
manufacturer’s instructions. Reverse transcription (RT) was performed using Reverse Transcription 
System kit (Promega, Madison, WI): 1 µg of total RNA was reverse transcribed in the presence of 
5 mM MgCl2, 1× Reverse transcription Buffer (10 mM Tris–HCl, 50 mM KCl, 0.1% Triton X-100), 
1 mM each dNTPs, 20 U recombinant Rnasin Ribonuclease Inhibitor, 15 U AMV Reverse 
Transcriptase, 0.5 µg Oligo(dT)15 primers in a total volume of 20 µl for 10 min at 70 °C and 60 min 
at 42 °C. The resulting cDNA was quantified by relative quantitative real-time PCR (real-time 
qPCR). For the Real-time qPCR, 5 µl of cDNA were used for each Sybr Green real-time PCR to 
quantify the relative IL-8 expression. The cDNA (5 µl) was then amplified for 40 PCR cycles using 
the SYBR Green PCR Master Mix (Applied Biosystems) in a 25 µl reaction using 7900HT Fast 
Real-Time PCR apparatus (Applied Biosystems, Foster City, CA). In order to perform the PCR 
reaction QuantiTect Primer assays (Qiagen, Hilden, Germany) for IL-8 (Hs_IL8_1_SG, 
NM_000584), IL-1β (Hs_IL1B_1_SG, NM_000576), IL-6 (Hs_IL6_1_SG, NM_000600), TNF-α 
(Hs_TNF_1_SG, NM_000594) and Actin-beta (ACTB) (Hs_ACTB_1_SG, NM_001101) were 
purchased.  The quantified real-time PCRs were performed in duplicates for both target and 
normalizer genes. Relative quantification of gene expression was performed utilizing the 
comparative threshold (CT) method. Changes in mRNA expression level were calculated following 
normalization with the ACTB calibrator gene and expressed as fold change over untreated samples. 
 
2.5. Statistics  
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Results are expressed as mean ± standard error (SEM). Comparisons between groups were made by 
using paired Student's t test and a one-way analysis of variance (ANOVA). Differences were 
considered significant when p<0.05 and highly significant when p<0.01. 
 
2.6. Bio-Plex-analysis 
IL-8 in tissue culture supernatants released from the cells under analysis, was measured by Bio-Plex 
cytokine assay (Bio-Rad Laboratories, Hercules, CA).
25, 26
 IL-8 standards or samples (supernatants 
recovered from treated cells) were incubated with anti-IL-8 conjugated beads in 96-well filter plates 
for 30 min at RT with shaking. Plates were then washed with Bio-Plex wash buffer, diluted 
detection antibody was added and were incubated for 30 min at RT with shaking. After washes, 
streptavidin-phycoerythrin was added and the plates were incubated for 10 min at RT with shaking. 
Finally, plates were washed by vacuum filtration three times, beads were suspended in Bio-Plex 
assay buffer, and samples were analyzed on a Bio-Rad 96-well plate reader using the Bio-Plex 
Suspension Array System and Bio-Plex Manager software (Bio-Rad Laboratories). 
 
2.7. Circular dichroism 
Circular dichroism (CD) spectra were recorded at 25 °C using a 1 cm quartz cell with the Jasco-715 
spectropolarimeter, a 260–198 nm measurement range, 100 nm/min scanning speed, 1 nm 
bandwidth, 4 s response time, 1.0 nm data pitch. LPS from P. aeruginosa 10 (Sigma, purified by 
phenol extraction) was employed for the experiments. The peptide TB_KKG6A was dissolved in 
phosphate buffer 10 mM pH 7.0 at a 5 µM concentration; the LPS was dissolved in phosphate 
buffer 10 mM pH 7.0 at a 0.75µg/µL concentration, before use it was subjected to temperature 
cycles between 4° and 70 °C, interrupted by vortexing (10 min). The sample was stored at 4 °C 
overnight.  LPS titrations were carried out recording the CD spectra of the peptide in the presence 
of increasing concentrations of LPS at 25 °C, adding aliquots of 18.7 µg LPS.  
 
2.8. Fluorescence studies 
LPS from P. aeruginosa 10 (Sigma, purified by phenol extraction) was employed for the 
experiments. The peptide TB_KKG6A-NBD was dissolved in phosphate buffer 10 mM pH 7.0 at a 
0.5 µM concentration, the LPS was dissolved in phosphate buffer 10 mM pH 7 at a 0.075µg/µL 
concentration. LPS titrations were carried out monitoring the fluorescence intensity at 550 nm of 
the peptide in the presence of increasing concentrations of LPS, from 1.8 to 28 µg. The excitation 
wavelength was set at 487 nm. The maximum emission wavelength vs the excitation wavelength 
were monitored for the peptide TB_KKG6A-NBD and for the mixture TB_KKG6A-NBD +18.7 µg 
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of P. aeruginosa LPS to detect possible red edge excitation shift effects.  All experiments were 
repeated in duplicate. 
 
3. Results and discussion 
 
3.1. Inhibition of P. aeruginosa cell growth after exposure to Temporin derivatives. 
 
P. aeruginosa strain PAO1 was exposed for 24 hours to increasing amounts of the peptides TB, 
TB_G6A , TB_KKG6A and gentamicin (Figure 1) as positive control, since this compound is one 
of the gold standards in the current antibiotic therapy on cystic fibrosis patients.
27
 As clearly 
evident, no inhibitory effects on PAO1 were displayed by TB and TB_G6A, even when 
administered at 25-50 µM concentrations (Figures 1A and 1B). Interestingly, TB_KKG6A 
displayed anti-PAO1 activity at 5 µM concentrations (Figure 1C), confirming the ability of the 
modified peptide to kill Gram negative bacteria; gentamicin was more active (full PAO1 
suppression obtained at 1 µM concentration) (Figure 1D), as elsewhere reported.
27
   
 
3.2. Effects of Temporin analogues on  P. aeruginosa induced upregulation of IL-8 gene 
expression. 
 
The results of this experiment are shown in Figure 2. Cystic fibrosis IB3-1 cells were exposed to the 
analyzed compound for 24 hours before infection with PAO1 for 4 hours and RNA isolation for IL-
8 mRNA content analysis. We found that TB and TB_G6A were inactive (Figure 2, A and B). On 
the contrary, TB_KKG6A displayed inhibitory activity, but only at high concentrations (10 and 50 
µM) (Figure 2C). As expected, gentamycin displayed inhibitory activity at 5-10 µM concentration 
(Figure 2D). These data indicate that TB_KKG6A, as gentamicin, exerts anti-inflammatory activity, 
by inhibiting the PAO1 induced up-regulation of IL-8 gene expression.  
 
3.3. Effects of pre-incubation of PAO1 with Temporin analogues on IL-8 gene expression. 
 
When PAO1 cells were pre-incubated for 24 hours with the peptides and then mixed with IB3-1 
cells, only TB_KKG6A exhibited strong inhibitory effects on accumulation of IL-8 mRNA (Figure 
3, panels A-C). Very strong effects were found at 5 µM concentration. As expected, gentamicin 
displayed inhibitory effects with higher efficiency  (Figure 3D). 
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3.4. Effects of temporin analogues on expression of IL-1β, IL-6 and TNF-α pro-inflammatory 
genes. 
 
The effects of pre-treatment of IB3-1 cells with the synthetic peptides before 4 hours PAO1 
infection were also determined by RT-PCR on other pro-inflammatory genes, such as IL-1β, IL-6 
and TNF-α. Surprisingly, TB was found to up-regulate the expression of two pro-inflammatory 
genes, IL-1β and IL-6 (Figure 4, A and B), while was inactive on TNF-α (Figure 4C). On the 
contrary, TB_G6A, as found for IL-8 (see Figure 2) exhibited no effect on the expression of IL-1β 
and TNF-α and only minor effects on IL-6 (Figure 4, D-F). By sharp contrast TB_KKG6A was 
found to significantly inhibit the expression of IL-1β, IL-6 and TNF-α (Figure 4, G-I). This 
suggests that TB_KKG6A is a strong inhibitor of PAO1 induced expression of pro-inflammatory 
genes. Fully in agreement with the results shown in Figure 3C, TB_KKG6A was found to abolish 
PAO1 induction of IL-1β, IL-6 and TNF-α gene expression when pre-incubated with PAO1, before 
infection of IB3-1 cells (Figure 5).  This suggests that TB_KKG6A is a strong inhibitor of PAO1 
induced expression of pro-inflammatory genes, working with an efficiency similar to that exhibited 
by gentamicin, extensively used as antibacterial drug on cystic fibrosis patients. 
 
3.5. Effects of TB_KKG6A on IL-8 release. 
 
In order to confirm that the effects of TB_KKG6A measured with RT-PCR (and therefore 
measuring IL-8 mRNA levels, see Figures 2 and 3) are accompanied by inhibition of IL-8 protein 
secretion, the levels of IL-8 protein were analyzed in the medium of cultured IB3-1 cells, following 
the protocols described for Figure 6A in the legends of Figures 2 and 4 and for Figure 6B in the 
legends of Figures 3 and 5. Fully in agreement with the RT-PCR data, Figure 6 shows that 
TB_KKG6A inhibits IL-8 secretion either when added to IB3-1 before PAO1 infection (Figure 6A) 
or when added to PAO1 before treatment of IB3-1 cells (Figure 6B). 
 
3.6. Effects of TB_KKG6A on expression of IL-1β, IL-6 and TNF-α pro-inflammatory genes 
in uninfected IB3-1 cells. 
 
In order to exclude an effect of TB_KKG6A on the basic levels of IL-8, IL-1β, IL-6 and TNF-α, the 
experiment reported in Figure 7 was performed. IB3-1 cells were treated for 24 hours with 50 µM 
TB, TB_G6A and TB_KKG6A and the expression of the pro-inflammatory genes IL-8, IL-1β, IL-6 
and TNF-α was determined by RT-PCR. The results obtained demonstrated that the peptides 
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TB_G6A and TB_KKG6A do not affect the expression of pro-inflammatory genes in uninfected 
IB3-1 cells. The only inhibitory effect was found when TB was employed and the expression of IL-
8 and IL-6 genes analyzed (Figure7, A and C). When these data are considered together with the 
results shown in Figures 2-5, they suggests that TB_KKG6A is a strong inhibitor of PAO1 induced 
expression of pro-inflammatory genes and its activity is mainly due to antibacterial effects without 
alteration of cellular pathways involved in inflammatory processes.  
 
 
3.7 CD and fluorescence studies 
As the antibacterial activity of peptides belonging to the temporin family is supposed to be 
mediated by the interactions of the peptides with the bacterial outer membrane, we performed CD 
and fluorescence studies of TB_KKG6A in the presence of P. aeruginosa LPS. The peptide 
TB_KKG6A was titrated with the lipopolysaccharide from P. aeruginosa in phosphate buffer at pH 
7.0 . CD spectra of the peptide in buffer show one minimum at 200 nm which clearly indicates that 
the peptide is in an unordered conformation in buffer, while in the presence of LPS two minima 
around 207 and 224 nm appear, suggesting that the peptide assumes the conformation of a helix 
upon binding to LPS. (Figure 8) The interaction of the peptide with LPS was also assessed by 
fluorescence, monitoring the intensity of the fluorescence emission of the NBD labeled 
TB_KKG6A, TB_KKG6A_NBD, titrated with increasing amounts of LPS. A sigmoidal curve was 
obtained plotting the fluorescence intensity at 550 nm vs µg of LPS added.(Figure 9) This result is 
very similar to what reported in the literature for titrations carried out for this and other NBD 
labeled peptides with LPS from other bacteria, as E.coli.
20, 28
 The binding of the peptide to LPS 
causes an increase in the hydrophobicity of the peptide environment which is sensed by the NBD 
probe. As it is reported in the literature that the LPS from P. aeruginosa has a high degree of 
heterogeneity
29
, we could not calculate its molar concentration and therefore we could not express 
the binding constant of the peptide to LPS.  In order to detect the position of the fluorophore with 
respect to the LPS, we also monitored how the maximum in the emission wavelength varies with 
the excitation wavelength. It has been observed, in  fact, that membrane bound peptides show red 
edge excitation shift (REES), due to the location of the fluorophore in a membrane region which is 
motionally restricted
30
. No REES was detected for the peptide in solution and for the peptide in the 
presence of LPS (data not shown), suggesting that the N-terminus of the peptide is solvent exposed. 
CD and fluorescence data demonstrate that the peptide interacts with the bacterial membrane and 
that its folding is mediated by the interaction with the bacterial LPS.  It has recently been 
demonstrated that  CD spectra recorded for antimicrobial peptides in the presence of LPS recall CD 
Page 9 of 25
http://mc.manuscriptcentral.com/jpsc
Journal of Peptide Science
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
spectra recorded in the presence of cells
31
; based on this we might hypothesize that the peptide 
TB_KKG6A also assumes an helical structure upon interaction with  P.aeruginosa cells. 
 
 
 
 Conclusions 
The major conclusion of this work is that TB_KKG6A exhibits strong antimicrobial activity on 
P.aeruginosa PAO1 cells, likely mediated by the interactions of the peptide with the bacterial 
membranes. Experiments aimed to evaluate the antimicrobial activity of TB_KKG6A were carried 
out in parallel also on TB, TB_G6A and gentamycin. Interestingly TB_KKG6A was found active 
against P. aeruginosa at 10 µM concentration, unlike the other peptides which were found inactive. 
Gentamicin shows activity at lower concentration. These results confirm the ability of TB_KKG6A 
to kill Gram negative bacteria at low concentrations. In addition, TB_KKG6A was found to 
strongly inhibit the PAO1 induced upregulation of the pro inflammatory genes IL-8, IL-1β, IL-6 
and TNF-α in IB3-1 cystic fibrosis cells infected by P. aeruginosa PAO1 in different conditions. 
This effect is mainly associated with the antibacterial activity of TB_KKG6A, and in fact it is 
particularly evident when PAO-1 was pre-treated with TB_KKG6A before infection of the IB3-1 
cells (Figure 5); moreover no inhibitory effects of TB_KKG6A were found on the expression of IL-
8, IL-1b, IL-6 and TNF-a genes in uninfected IB3-1 cells (Figure 7). In any case inhibitory effects 
of TB_KKG6A are clearly detectable in IB3-1-infected cells in the protocol mimicking the 
pathological situation and based on pre-treatment of IB3-1 cells with the inhibitory peptide before 
infection. TB_KKG6A. The effects of TB_KKG6A on IL-8 gene expression are of relevance in 
consideration of the key role of this protein in cystic fibrosis inflammatory process. On the other 
hand TB was found to be inactive on IL-8 and TNF-α gene expression, but to exert induction 
effects on pro-inflammatory IL-1β and IL-6 genes, suggesting that TB should be considered as a 
potential pro-inflammatory compound.  
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Table 1. Name and sequences of the peptides employed. 
 
Sequence Name 
LLPIVGNLLKSLL TB 
LLPIVANLLKSLL TB_G6A 
KKLLPIVANLLKSLL TB_KKG6A 
NBD-Ahx-KKLLPIVANLLKSLL TB_ KKG6A _NBD 
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Legend to Figures 
 
Figure 1. Anti-microbial assay of Temporin B and its derivatives against P. aeruginosa.  Effects of 
increasing amounts of TB (A), TB_G6A (B),  TB_KKG6A (C) and Gentamicin (positive control) 
(D) on P. aeruginosa growth in TSB after 24 hours at 37°C.   
 
Figure 2.  Effects of pre-incubation of Temporin B and its derivatives in human bronchial epithelial 
cells before infection with P. aeruginosa. IB3-1 cells were pre-incubated with increasing amounts 
of TB, TB derivatives or Gentamicin for 24 hrs before P. aeruginosa (PAO1 strain) infection 
sustained for further 4 hours. Total RNA was finally extracted and qRT-PCR was performed in 
order to quantify IL-8 mRNA expression. Effects of pre-incubation of TB (A), TB_G6A (B),  
TB_KKG6A (C), Gentamicin (D). 
 
Figure 3. Effect of pre-incubation of Temporin B and its derivatives with P. aeruginosa on PAO1-
mediated IL-8 mRNA expression in human bronchial epithelial cells. Equal amounts of P. 
aeruginosa, PAO1 strain, were pre-incubated for 24 hours in TSB culture medium containing 
increasing amounts of TB, TB derivatives or Gentamicin. Then, the resulting bacterial suspension 
was washed with sterile PBS and IB3-1 cells were infected with the bacterial suspension obtained 
after PBS washes for 4 hours. Total RNA was extracted and mRNA was quantified by qRT-PCR. 
Effect of pre-incubation of TB (A), TB_G6A (B), TB_KKG6A (C), Gentamicin ( D). 
 
Figure 4. Effect of pre-incubation of Temporin B and its derivatives in human bronchial epithelial 
cells before infection with P. aeruginosa: expression of pro-inflammatory IL-1β, IL-6 and TNF-α 
genes. IB3-1 cells were pre-incubated with increasing amounts of TB and TB derivatives for 24 hrs 
before PAO1infection sustained for further 4 hours. Total RNA was finally extracted and qRT-PCR 
was performed in order to quantify IL-1β, IL-6 and TNF-α mRNAs. A-C. Effect of pre-incubation 
with TB on IL-1β (A), IL-6 (B) and TNF-α (C); D-F. Effect of TB_G6A on IL-1β (D), IL-6 (E) and 
TNF-α (F); G-I) effect of TB_KKG6A on  IL-1β (G), IL-6 (H) and TNF-α (I). 
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Figure 5.  Effect of pre-incubation of P.aeruginosa with TB_KKG6A (A-C) or Gentamycin (D-F) 
on PAO1-mediated IL-1β (A,D), IL-6 (B,E) and TNF-α (C,F) mRNA expression in IB3-1 cells. 
Equal amounts of P. aeruginosa, PAO1 strain, were pre-incubated for 24 hours in TSB culture 
medium containing increasing amount of TB_KKG6A  or Gentamicin. Then, the resulting bacterial 
suspension was washed with sterile PBS and IB3-1 cells were infected with the bacterial suspension 
obtained after PBS washes for 4 hours. Total RNA was extracted and mRNA was quantified by 
qRT-PCR.  
 
 
Figure 6. Effects of TB_KKG6A of IL-8 secretion. A. Effects of pre-incubation of human 
bronchial epithelial IB3-1 cells with the peptide before infection with P.aeruginosa (for details on 
the experimental protocol, see legend to Figs. 2 and 4). B. Effects of pre-incubation of the peptide 
with P. aeruginosa before infection of IB3-1 cells (for details on the experimental protocol, see 
legend to Figs. 3 and 5). IL-8 was quantified by Bio-plex analysis. Open symbols: control 
uninfected cells. 
 
 
Figure 7.  Effect of TB, TB_G6A  and TB_KKG6A (A-C) on accumulation of IL-8 (A), IL-1β (B), 
IL-6 (C) and TNF-α (D) in uninfected IB3-1 cells. The treatments were carried out for 24 hours at 
50 µM concentration of the peptides. Total RNA was extracted and mRNA was quantified by qRT-
PCR.  
 
Figure 8. Superimposition of CD spectra obtained titrating  P. aeruginosa LPS into the 
TB_KKG6A (5µM) solution, in phosphate buffer pH7.  The direction of the arrow indicates 
increasing LPS concentration. 
 
Figure 9. Plot of the fluorescence intensity at 550 nm vs µg P.aeruginosa LPS obtained titrating the 
LPS into the TB_KKG6A_NBD (0.5 µM) solution. 
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Figure 1. Anti-microbial assay of Temporin B and its derivatives against P. aeruginosa.  Effects of increasing 
amounts of TB (A), TB_G6A (B),  TB_KKG6A (C) and Gentamicin (positive control) (D) on P. aeruginosa 
growth in TSB after 24 hours at 37°C.    
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Figure 2.  Effects of pre-incubation of Temporin B and its derivatives in human bronchial epithelial cells 
before infection with P. aeruginosa. IB3-1 cells were pre-incubated with increasing amounts of TB, TB 
derivatives or Gentamicin for 24 hrs before P. aeruginosa (PAO1 strain) infection sustained for further 4 
hours. Total RNA was finally extracted and qRT-PCR was performed in order to quantify IL-8 mRNA 
expression. Effects of pre-incubation of TB (A), TB_G6A (B),  TB_KKG6A (C), Gentamicin (D).  
133x95mm (300 x 300 DPI)  
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Figure 3. Effect of pre-incubation of Temporin B and its derivatives with P. aeruginosa on PAO1-mediated IL-
8 mRNA expression in human bronchial epithelial cells. Equal amounts of P. aeruginosa, PAO1 strain, were 
pre-incubated for 24 hours in TSB culture medium containing increasing amounts of TB, TB derivatives or 
Gentamicin. Then, the resulting bacterial suspension was washed with sterile PBS and IB3-1 cells were 
infected with the bacterial suspension obtained after PBS washes for 4 hours. Total RNA was extracted and 
mRNA was quantified by qRT-PCR. Effect of pre-incubation of TB (A), TB_G6A (B), TB_KKG6A (C), 
Gentamicin ( D).  
152x124mm (600 x 600 DPI)  
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Figure 4. Effect of pre-incubation of Temporin B and its derivatives in human bronchial epithelial cells before 
infection with P. aeruginosa: expression of pro-inflammatory IL-1β, IL-6 and TNF-α genes. IB3-1 cells were 
pre-incubated with increasing amounts of TB, TB derivatives or Gentamicin for 24 hrs before PAO1infection 
sustained for further 4 hours. Total RNA was finally extracted and qRT-PCR was performed in order to 
quantify IL-1β, IL-6 and TNF-α mRNAs. A-C. Effect of pre-incubation with TB on IL-1β (A), IL-6 (B) and TNF-
α (C); D-F. Effect of TB_G6A on IL-1β (D), IL-6 (E) and TNF-α (F); G-I) effect of TB_KKG6A on  IL-1β (G), 
IL-6 (H) and TNF-α (I).  
126x86mm (600 x 600 DPI)  
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Figure 5. Effect of pre-incubation of P.aeruginosa with TB_KKG6A (A-C) or Gentamycin (D-F) on PAO1-
mediated IL-1β (A,D), IL-6 (B,E) and TNF-α (C,F) mRNA expression in IB3-1 cells. Equal amounts of P. 
aeruginosa, PAO1 strain, were pre-incubated for 24 hours in TSB culture medium containing increasing 
amount of TB_KKG6A  or Gentamicin. Then, the resulting bacterial suspension was washed with sterile PBS 
and IB3-1 cells were infected with the bacterial suspension obtained after PBS washes for 4 hours. Total 
RNA was extracted and mRNA was quantified by qRT-PCR.  
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Figure 6. Effects of TB_KKG6A of IL-8 secretion. A. Effects of pre-incubation of human bronchial epithelial 
IB3-1 cells with the peptide before infection with P.aeruginosa (for details on the experimental protocol, see 
legend to Figs. 2 and 4). B. Effects of pre-incubation of the peptide with P. aeruginosa before infection of 
IB3-1 cells (for details on the experimental protocol, see legend to Figs. 3 and 5). IL-8 was quantified by 
Bio-plex analysis. Open symbols: control unifected cells.  
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Figure 7.  Effect of TB, TB_G6A  and TB_KKG6A (A-C) on accumulation of IL-8 (A), IL-1β (B), IL-6 (C) and 
TNF-α (D) in uninfected IB3-1 cells. The treatments were carried out for 24 hours at 50 µM concentration of 
the peptides. Total RNA was extracted and mRNA was quantified by qRT-PCR.  
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Figure 8. Superimposition of CD spectra obtained titrating  P. aeruginosa LPS into the TB_KKG6A (5µM) 
solution, in phosphate buffer pH 7.  The direction of the arrow indicates increasing LPS concentration.  
6x5mm (600 x 600 DPI)  
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Figure 9. Plot of the fluorescence intensity at 550 nm vs µg P.aeruginosa LPS obtained titrating the LPS into 
the TB_KKG6A_NBD (0.5 µM) solution.  
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